Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

BACKGROUND: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and\or proinflammatory cytokine release. Thromboprophylaxis with enoxaparin is recommended by current guidelines, but evidence is st...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :EClinicalMedicine
Главные авторы: Albani, Filippo, Sepe, Lilia, Fusina, Federica, Prezioso, Chiara, Baronio, Manuela, Caminiti, Federica, Di Maio, Antonella, Faggian, Barbara, Franceschetti, Maria Elena, Massari, Marco, Salvaggio, Marcello, Natalini, Giuseppe
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2020
Предметы:
Research paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534836/
https://ncbi.nlm.nih.gov/pubmed/33043287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100562
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы